Lundstrom Brian 4
4 · ACADIA PHARMACEUTICALS INC · Filed Sep 14, 2007
Insider Transaction Report
Form 4
Lundstrom Brian
Sr. VP, Bus. Devt.
Transactions
- Sale
Common Stock
2007-09-12$16.00/sh−4,300$68,800→ 800 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-09-12−5,100→ 78,918 totalExercise: $6.61Exp: 2014-11-23→ Common Stock (5,100 underlying) - Exercise/Conversion
Common Stock
2007-09-12$6.61/sh+5,100$33,711→ 5,100 total - Sale
Common Stock
2007-09-12$16.02/sh−100$1,602→ 700 total - Sale
Common Stock
2007-09-12$16.03/sh−700$11,221→ 0 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were made pursuant to an automatic sales plan under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The plan provides for the non-discretionary periodic sales of stock (and corresponding exercises of options, if needed) pursuant to predetermined trading parameters that do not permit Mr. Lundstrom to exercise any influence over how, when or whether to effect trades under the plan after its adoption.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable on November 24, 2005. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.